Company: RGNX
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001193125-25-174953
Chunk: 0

Company: REGENXBIO Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
REGENXBIO INC.

CONSOLIDATED BALANCE SHEETS

(unaudited)

(in thousands, except per share data)

     June 30, 2025

     December 31, 2024

     Assets

     Current assets

     Cash and cash equivalents
      
     $
     79,558

     $
     57,526

     Marketable securities

     243,740

     177,161

     Accounts receivable

     20,199

     20,473

     Prepaid expenses

     10,776

     9,067

     Other current assets

     19,479

     13,774

     Total current assets

     373,752

     278,001

     Marketable securities

     40,296

     10,179

     Accounts receivable

     1,584

     474

     Property and equipment, net

     111,017

     117,589

     Operating lease right-of-use assets

     50,469

     53,716

     Restricted cash

     2,030

     2,030

     Other assets

     1,879

     4,000

     Total assets
      
     $
     581,027

     $
     465,989

     Liabilities and Stockholders’ Equity

     Current liabilities

     Accounts payable
      
     $
     21,655

     $
     22,798

     Accrued expenses and other current liabilities

     35,557

     38,070

     Deferred revenue

     13,977

     115

     Operating lease liabilities

     8,049

     7,902

     Royalty monetization liabilities

     40,302

     34,309

     Total current liabilities

     119,540

     103,194

     Deferred revenue

     23,804

     —

     Operating lease liabilities

     69,647

     74,131

     Royalty monetization liabilities

     153,693

     25,378

     Other liabilities

     664

     3,635

     Total liabilities

     367,348

     206,338

     Stockholders’ equity

     Preferred stock; $0.0001 par value; 10,000 shares authorized,